Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma

Respir Investig. 2016 Sep;54(5):372-5. doi: 10.1016/j.resinv.2016.04.001. Epub 2016 Jun 6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology*
  • ErbB Receptors / genetics*
  • Erlotinib Hydrochloride / administration & dosage*
  • Female
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology*
  • Meningeal Neoplasms / drug therapy*
  • Meningeal Neoplasms / secondary
  • Middle Aged
  • Mutation*

Substances

  • Erlotinib Hydrochloride
  • ErbB Receptors